Black Swan Sale

50% Off Elite

Get our most powerful screeners, new charting tools, and the fastest ad-
free experience at our best price ever. This deal may never happen again.

FLGT

Fulgent Genetics Inc

Nov 26 • 04:00PM ET

30.15

-0.70 -2.27 %

Healthcare • Diagnostics & Research • USA • NASD

Peers: ILMN QGEN EXAS GH CDNA TXG ONC VCYT MYGN OMIC

| Held by: IWM VTI IWN VXF FNDA IBB DFAT SCHA DFAS DFAC

Scroll to Statements

Index	RUT	P/E	-	EPS (ttm)	-1.40	Insider Own	35.47%	Shs Outstand	30.85M	Perf Week	3.97%
Market Cap	932.01M	Forward P/E	-	EPS next Y	-0.32	Insider Trans	-0.20%	Shs Float	19.97M	Perf Month	28.68%
Enterprise Value	559.07M	PEG	-	EPS next Q	0.03	Inst Own	56.02%	Short Float	9.34%	Perf Quarter	36.86%
Income	-42.98M	P/S	2.95	EPS this Y	-42.88%	Inst Trans	5.43%	Short Ratio	6.75	Perf Half Y	46.29%
Sales	315.55M	P/B	0.83	EPS next Y	-214.35%	ROA	-3.51%	Short Interest	1.87M	Perf YTD	63.24%
Book/sh	36.49	P/C	2.48	EPS next 5Y	-	ROE	-3.80%	52W High	31.04 -2.87%	Perf Year	68.72%
Cash/sh	12.16	P/FCF	-	EPS past 3/5Y	- -129.89%	ROIC	-3.80%	52W Low	14.57 106.93%	Perf 3Y	-17.87%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	-34.15% 54.19%	Gross Margin	38.71%	Volatility	3.52% 4.34%	Perf 5Y	-27.63%
Dividend TTM	-	EV/Sales	1.77	EPS Y/Y TTM	74.64%	Oper. Margin	-22.50%	ATR (14)	1.08	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	7.01	Sales Y/Y TTM	13.60%	Profit Margin	-13.62%	RSI (14)	71.49	Recom	2.00
Dividend Gr. 3/5Y	- -	Current Ratio	7.01	EPS Q/Q	55.38%	SMA20	11.03%	Beta	0.60	Target Price	33.67
Payout	-	Debt/Eq	0.01	Sales Q/Q	17.18%	SMA50	22.77%	Rel Volume	0.88	Prev Close	30.85
Employees	1313	LT Debt/Eq	0.01	Earnings	Nov 07 BMO	SMA200	46.77%	Avg Volume	276.40K	Price	30.15
IPO	Sep 29, 2016	Option/Short	Yes / Yes	EPS/Sales Surpr.	162.44% 3.24%	Trades		Volume	241,932	Change	-2.27%

Date	Action	Analyst	Rating Change	Price Target Change
Aug-05-25	Upgrade	UBS	Neutral → Buy	$30
Dec-07-23	Initiated	UBS	Neutral	$35
Dec-08-22	Downgrade	Piper Sandler	Overweight → Neutral	$65 → $40
Nov-18-22	Initiated	Raymond James	Outperform	$45
Aug-25-22	Initiated	Credit Suisse	Outperform	$65
Feb-04-22	Resumed	Piper Sandler	Overweight	$80
Aug-05-21	Resumed	Credit Suisse	Underperform	$55
Jan-08-21	Downgrade	Credit Suisse	Neutral → Underperform	$42 → $40
Nov-24-20	Downgrade	BTIG Research	Buy → Neutral
Aug-20-20	Initiated	Oppenheimer	Outperform	$75
May-29-20	Initiated	BTIG Research	Buy	$20
Nov-05-19	Upgrade	Piper Jaffray	Neutral → Overweight
Mar-01-18	Downgrade	Piper Jaffray	Overweight → Neutral
Nov-07-17	Downgrade	Raymond James	Outperform → Mkt Perform

Show Previous Ratings

Nov-08-25 02:05AM	Fulgent Genetics Inc (FLGT) Q3 2025 Earnings Call Highlights: Strong Revenue Growth and Upward ... (GuruFocus.com)
Nov-07-25 04:05PM	Fulgent to Participate in Upcoming Conferences (Business Wire) +18.15%
08:20AM	Fulgent Genetics, Inc. (FLGT) Surpasses Q3 Earnings and Revenue Estimates (Zacks)
07:05AM	Fulgent Reports Third Quarter 2025 Financial Results (Business Wire)
Nov-06-25 06:35PM	Evolent Health (EVH) Misses Q3 Earnings Estimates (Zacks)
07:05AM	Loading…
Oct-21-25 07:05AM	Strength Seen in Schrodinger (SDGR): Can Its 13.8% Jump Turn into More Strength? (Zacks)
Oct-20-25 06:00AM	Fulgent Shares Preliminary Data from Poster Presentation at ESMO 2025 Conference (Business Wire) +5.11%
Oct-16-25 07:00AM	Fulgent to Announce Third Quarter 2025 Financial Results on Friday, November 7, 2025 (Business Wire)
Sep-11-25 07:00PM	Fulgent Genetics: A Risky Bet or a Hidden Gem? (Motley Fool)
Aug-02-25 03:07AM	Fulgent Genetics Inc (FLGT) Q2 2025 Earnings Call Highlights: Strong Core Revenue Growth Amid ... (GuruFocus.com)
Aug-01-25 04:26PM	Why Fulgent Genetics Stock Was Crushing It on Friday (Motley Fool) +7.86%
08:10AM	Fulgent Genetics, Inc. (FLGT) Surpasses Q2 Earnings and Revenue Estimates (Zacks)
07:00AM	Fulgent Reports Second Quarter 2025 Financial Results (Business Wire)
Jul-17-25 07:00AM	Fulgent Genetics Receives EU CE Mark for FulgentExome & FulgentPLM (Business Wire)
Jul-10-25 04:05PM	Fulgent to Announce Second Quarter 2025 Financial Results on Friday, August 1, 2025 (Business Wire)
08:11AM	Loading…
May-19-25 08:11AM	Wolf Haldenstein Adler Freeman & Herz LLP is investigating Fulgent Genetics, Inc (PR Newswire)
May-03-25 03:03AM	Fulgent Genetics Inc (FLGT) Q1 2025 Earnings Call Highlights: Navigating Growth and Challenges (GuruFocus.com)
May-02-25 11:35PM	Q1 2025 Fulgent Genetics Inc Earnings Call (Thomson Reuters StreetEvents) +19.07%
12:27PM	Fulgent Genetics, Inc. (FLGT) Q1 2025 Earnings Call Transcript (Seeking Alpha)
08:10AM	Fulgent Genetics, Inc. (FLGT) Q1 Earnings and Revenues Beat Estimates (Zacks)
07:00AM	Fulgent Reports First Quarter 2025 Financial Results (Business Wire)
Apr-21-25 04:37PM	Fulgent Genetics Inc (FLGT) Q4 2024 Earnings Call Highlights: Strong Revenue Growth Amid ... (GuruFocus.com)
Apr-10-25 04:05PM	Fulgent to Announce First Quarter 2025 Financial Results on Friday, May 2, 2025 (Business Wire) +9.64%
Apr-04-25 02:30PM	Stock Picks From Seeking Alpha's March 2025 New Analysts (Seeking Alpha)
Mar-24-25 08:01AM	Hims & Hers Health (HIMS) Moves 5.7% Higher: Will This Strength Last? (Zacks)
Mar-20-25 05:46AM	Fulgent Genetics: Undervalued, CFO Buying, And Promising Drug Candidates Make It A Buy (SeekingAlpha)
Mar-07-25 06:19PM	DoorDash, TKO Group Holdings, Williams-Sonoma and Expand Energy Set to Join S&P 500; Others to Join S&P 100, S&P MidCap 400 and S&P SmallCap 600 (PR Newswire) -9.20%
Feb-28-25 11:30PM	Q4 2024 Fulgent Genetics Inc Earnings Call (Thomson Reuters StreetEvents)
08:10AM	Fulgent Genetics, Inc. (FLGT) Q4 Earnings and Revenues Beat Estimates (Zacks)
07:00AM	Fulgent Reports Fourth Quarter and Full Year 2024 Financial Results (Business Wire)
04:05PM	Loading…
Feb-06-25 04:05PM	Fulgent to Announce Fourth Quarter and Full Year 2024 Financial Results on Friday, February 28, 2025 (Business Wire)
Dec-09-24 09:55AM	Wall Street Analysts Predict a 31.06% Upside in Fulgent Genetics (FLGT): Here's What You Should Know (Zacks)
Nov-22-24 12:00PM	All You Need to Know About Fulgent Genetics (FLGT) Rating Upgrade to Strong Buy (Zacks) +5.43%
Nov-19-24 07:16PM	Fulgent Genetics, Inc. (FLGT): Among the Best Genomics Stocks to Buy Right Now (Insider Monkey)
Nov-09-24 07:31AM	Fulgent Genetics Reports Strong Q3 2024 Results (TipRanks)
02:05AM	Fulgent Genetics Inc (FLGT) Q3 2024 Earnings Call Highlights: Strategic Growth Amid Revenue Decline (GuruFocus.com)
Nov-08-24 08:15AM	Fulgent Genetics, Inc. (FLGT) Surpasses Q3 Earnings and Revenue Estimates (Zacks) -11.76%
07:00AM	Fulgent Reports Third Quarter 2024 Financial Results (Business Wire)
Nov-05-24 08:00AM	Fulgent to Participate in Upcoming Conferences (Business Wire)
Nov-01-24 08:08AM	Fulgent Genetics (FLGT) Surges 5.8%: Is This an Indication of Further Gains? (Zacks)
Oct-31-24 08:00AM	Fulgent Genetics Awarded Contract by the U.S. Department of Veterans Affairs to Provide Hereditary Cancer, Pharmacogenetic and Other Genetic Testing to Veterans1 (Business Wire) +5.82%
Oct-17-24 04:05PM	Fulgent to Announce Third Quarter 2024 Financial Results on Friday, November 8, 2024 (Business Wire)
Aug-13-24 12:00PM	Fulgent Genetics (FLGT) Upgraded to Buy: What Does It Mean for the Stock? (Zacks)
09:55AM	How Much Upside is Left in Fulgent Genetics (FLGT)? Wall Street Analysts Think 27.22% (Zacks)
Aug-02-24 08:15AM	Fulgent Genetics, Inc. (FLGT) Beats Q2 Earnings and Revenue Estimates (Zacks) +6.32%
07:00AM	Fulgent Reports Second Quarter 2024 Financial Results (Business Wire)
Jul-18-24 04:36AM	Fulgent Genetics (FLGT) Soars 6.6%: Is Further Upside Left in the Stock? (Zacks) -5.53%
Jul-11-24 04:05PM	Fulgent to Announce Second Quarter 2024 Financial Results on Friday, August 2, 2024 (Business Wire) +5.41%
Jun-10-24 01:00AM	Press release Biocartis NV: Biocartis Welcomes Gina Wallar, PhD as Chief Business Officer and Judith Vacchino, PhD as VP Global Marketing (GlobeNewswire)
Jun-03-24 08:00AM	Fulgent Data at ASCO 2024 Highlights Antitumor Activity from Lead Therapeutic Oncology Candidate, FID-007, in Head and Neck Cancer (Business Wire)
May-24-24 08:00AM	Fulgent Announces Upcoming Presentation of Clinical Data for Its Lead Therapeutic Oncology Candidate, FID-007, at ASCO 2024 Annual Meeting (Business Wire)
May-15-24 04:21AM	Moffitt and Fulgent Pharma partner on personalised cancer therapies (Pharmaceutical Technology)
May-14-24 04:05PM	Moffitt Cancer Center and Fulgent Pharma Join Forces to Revolutionize Cancer Therapeutics (Business Wire)
09:00AM	Brixton Biosciences Announces $33M in Series B Funding to Advance Novel Technology for the Treatment of Pain (PR Newswire)
May-04-24 09:15AM	Fulgent Genetics, Inc. (NASDAQ:FLGT) Q1 2024 Earnings Call Transcript (Insider Monkey)
03:04AM	Fulgent Genetics Inc (FLGT) Q1 2024 Earnings Call Transcript Highlights: Navigating Challenges ... (GuruFocus.com)
May-03-24 10:46PM	Q1 2024 Fulgent Genetics Inc Earnings Call (Thomson Reuters StreetEvents)
11:53AM	FLGT Stock Earnings: Fulgent Genetics Beats EPS, Misses Revenue for Q1 2024 (InvestorPlace)
08:34AM	Fulgent Genetics Inc (FLGT) Q1 2024 Earnings: Misses Analyst Forecasts with Wider Losses (GuruFocus.com)
08:15AM	Fulgent Genetics, Inc. (FLGT) Reports Q1 Loss, Misses Revenue Estimates (Zacks)
07:00AM	Fulgent Reports First Quarter 2024 Financial Results (Business Wire)
Apr-11-24 04:05PM	Fulgent Genetics to Announce First Quarter 2024 Financial Results on Friday, May 3, 2024 (Business Wire)
Feb-29-24 09:31AM	Fulgent Genetics, Inc. (NASDAQ:FLGT) Q4 2023 Earnings Call Transcript (Insider Monkey)
Feb-28-24 10:18PM	Q4 2023 Fulgent Genetics Inc Earnings Call (Thomson Reuters StreetEvents) -8.14%
07:35AM	Fulgent Genetics Inc (FLGT) Faces GAAP Loss Despite Core Revenue Growth in 2023 (GuruFocus.com)
07:00AM	Fulgent Reports Fourth Quarter and Full Year 2023 Financial Results (Business Wire)
Feb-13-24 08:00AM	Fulgent Genetics to Announce Fourth Quarter and Full Year 2023 Financial Results on Wednesday, February 28, 2024 (Business Wire)
Feb-09-24 08:31AM	Cord Blood Registry (CBR) by CooperSurgical and Fulgent Genetics Launch Innovative Genetic Testing (PR Newswire)
Nov-25-23 09:45AM	The 3 Best Digital Health Stocks for Personalized Medicine (InvestorPlace)
Nov-14-23 04:30PM	Fulgent to Participate in the Piper Sandler 35th Annual Healthcare Conference (Business Wire)
Nov-05-23 09:02AM	Fulgent Genetics, Inc. (NASDAQ:FLGT) Q3 2023 Earnings Call Transcript (Insider Monkey)
Nov-03-23 10:26PM	Q3 2023 Fulgent Genetics Inc Earnings Call (Thomson Reuters StreetEvents) +13.24%
04:05PM	Fulgent Shares Data from Two Poster Presentations at SITC 2023 Annual Meeting (Business Wire)
08:52AM	Fulgent Genetics Inc (FLGT) Reports Q3 2023 Financial Results (GuruFocus.com)
08:45AM	Fulgent Genetics, Inc. (FLGT) Reports Q3 Loss, Tops Revenue Estimates (Zacks)
07:00AM	Fulgent Reports Third Quarter 2023 Financial Results (Business Wire)
Oct-30-23 03:46PM	Top 20 Genomics Companies in the World (Insider Monkey)
Oct-25-23 08:00AM	Fulgent Announces Two Poster Presentations at SITC 2023 Annual Meeting (Business Wire)
Oct-18-23 09:44AM	Strength Seen in Olink Holding AB (publ) Sponsored ADR (OLK): Can Its 66.0% Jump Turn into More Strength? (Zacks)
Oct-17-23 08:00AM	Fulgent Genetics to Announce Third Quarter 2023 Financial Results on Friday November 3, 2023 (Business Wire)
Aug-05-23 08:56AM	Fulgent Genetics, Inc. (NASDAQ:FLGT) Q2 2023 Earnings Call Transcript (Insider Monkey)
Aug-04-23 10:08PM	Q2 2023 Fulgent Genetics Inc Earnings Call (Thomson Reuters StreetEvents) -12.82%
08:15AM	Fulgent Genetics, Inc. (FLGT) Reports Q2 Loss, Tops Revenue Estimates (Zacks)
07:00AM	Fulgent Reports Second Quarter 2023 Financial Results (Business Wire)
Jul-24-23 04:05PM	Exagen Inc. Appoints Paul Kim to Board of Directors (GlobeNewswire)
Jul-18-23 08:00AM	Fulgent Genetics to Announce Second Quarter 2023 Financial Results on Friday, August 4, 2023 (Business Wire)
Jun-21-23 08:00PM	FLGT: Lowering target price to $29.00 (Argus Research)
Jun-14-23 11:40AM	10 DNA Stocks Billionaires Are Loading Up On (Insider Monkey)
Jun-06-23 07:45AM	Got $2,500? This Dirt Cheap Growth Stock Could Be Worth Buying Hand Over Fist (Motley Fool)
Jun-05-23 08:30AM	Fulgent Data at ASCO 2023 Highlights Progress for Its Lead Therapeutic Oncology Candidate, FID-007, in Various Cancers (Business Wire)
May-23-23 09:53AM	Better Diversified Biotech Stock: 23andMe vs. Fulgent Genetics (Motley Fool)
08:20AM	2 Undervalued Stocks to Buy for Potentially Massive Gains in the Next 10 Years (Motley Fool)
May-18-23 04:05PM	Fulgent Announces Upcoming Presentation of Clinical Data for Its Lead Therapeutic Oncology Candidate, FID-007, at ASCO 2023 Annual Meeting (Business Wire) +6.13%
May-08-23 11:15AM	3 Cash-Rich Biotechs in a Market That's Tough on the Debt Burdened (TheStreet.com)
09:40AM	Is Fulgent Genetics (FLGT) Stock Outpacing Its Medical Peers This Year? (Zacks)
May-05-23 08:15AM	Fulgent Genetics, Inc. (FLGT) Reports Q1 Loss, Tops Revenue Estimates (Zacks) +18.97%
07:00AM	Fulgent Reports First Quarter 2023 Financial Results (Business Wire)
Apr-26-23 08:00PM	FLGT: Rating increased to a HOLD (Argus Research)
Apr-20-23 04:05PM	Fulgent Genetics to Announce First Quarter 2023 Financial Results on Friday May 5, 2023 (Business Wire)
Apr-16-23 02:01PM	7 Stocks to Buy to Bag Big-Time Returns in Q2 (InvestorPlace)

Fulgent Genetics, Inc. is a technology company, which engages in the provision of gene testing and sequencing solutions. It offers genes and panels, known mutation, hereditary cancer, carrier screening, and tumor profiling solutions. The company was founded by Ming Hsieh on May 13, 2016 and is headquartered in El Monte, CA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Xie Jian	Officer	Nov 28 '25	Proposed Sale	30.15	1,198	36,120		Nov 26 08:26 PM
Gao Hanlin	Officer	Nov 28 '25	Proposed Sale	30.15	943	28,431		Nov 26 08:24 PM
Xie Jian	President and COO	Nov 24 '25	Sale	30.47	681	20,752	339,087	Nov 25 04:30 PM
Gao Hanlin	Chief Scientific Officer	Nov 24 '25	Sale	30.47	535	16,303	954,908	Nov 25 04:30 PM
Xie Jian	Officer	Nov 24 '25	Proposed Sale	30.47	681	20,752		Nov 24 06:37 PM
Gao Hanlin	Officer	Nov 24 '25	Proposed Sale	30.47	535	16,303		Nov 24 06:36 PM
Xie Jian	President and COO	Nov 19 '25	Sale	29.10	10,000	290,983	349,768	Nov 21 04:30 PM
Xie Jian	Officer	Nov 19 '25	Proposed Sale	29.10	10,000	290,983		Nov 19 08:03 PM
Gao Hanlin	Chief Scientific Officer	Sep 03 '25	Sale	22.03	1,063	23,414	957,085	Sep 03 05:33 PM
Xie Jian	President and COO	Sep 03 '25	Sale	22.03	1,128	24,846	364,121	Sep 03 05:33 PM
Xie Jian	Officer	Sep 03 '25	Proposed Sale	22.03	1,128	24,846		Sep 03 05:29 PM
Gao Hanlin	Officer	Sep 03 '25	Proposed Sale	22.03	1,063	23,414		Sep 03 05:29 PM
Xie Jian	President and COO	Aug 27 '25	Sale	21.48	1,199	25,760	365,249	Aug 28 06:55 PM
Gao Hanlin	Chief Scientific Officer	Aug 27 '25	Sale	21.48	943	20,260	958,148	Aug 28 06:55 PM
Xie Jian	Officer	Aug 27 '25	Proposed Sale	21.48	1,199	25,760		Aug 27 07:49 PM
Gao Hanlin	Officer	Aug 27 '25	Proposed Sale	21.48	943	20,260		Aug 27 07:47 PM
Xie Jian	President and COO	Aug 25 '25	Sale	21.50	696	14,965	366,448	Aug 26 07:13 PM
Gao Hanlin	Chief Scientific Officer	Aug 25 '25	Sale	21.50	548	11,783	959,091	Aug 26 07:10 PM
Xie Jian	Officer	Aug 25 '25	Proposed Sale	21.50	696	14,965		Aug 25 08:24 PM
Gao Hanlin	Chief Scientific Officer	Jun 02 '25	Sale	20.29	754	15,299	961,281	Jun 03 04:47 PM
Xie Jian	President and COO	Jun 02 '25	Sale	20.29	1,135	23,030	371,496	Jun 03 04:46 PM
Xie Jian	Officer	Jun 02 '25	Proposed Sale	20.29	1,135	23,030		Jun 02 04:49 PM
Xie Jian	President and COO	May 27 '25	Sale	20.54	1,873	38,468	372,631	May 28 04:17 PM
Gao Hanlin	Chief Scientific Officer	May 27 '25	Sale	20.54	1,039	21,339	962,035	May 28 04:16 PM
Kim Paul	CFO and Treasurer	Mar 05 '25	Buy	15.96	100,000	1,596,470	348,282	Mar 05 06:47 PM
Xie Jian	President and COO	Dec 03 '24	Sale	19.50	1,455	28,372	334,681	Dec 04 04:41 PM
Gao Hanlin	Chief Scientific Officer	Dec 03 '24	Sale	19.50	1,373	26,773	919,469	Dec 04 04:40 PM
Gao Hanlin	Officer	Dec 02 '24	Proposed Sale	19.25	1,397	26,892		Dec 02 07:10 PM
Xie Jian	Officer	Dec 02 '24	Proposed Sale	19.25	1,483	28,548		Dec 02 07:10 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

Black Swan Sale

50% Off Elite

FLGT

Fulgent Genetics Inc

Upgrade your FINVIZ experience